Literature DB >> 12540312

Management of acne.

David C Liao1.   

Abstract

Precise classification methods are used to define acne according to type (comedonal, papulopustular, or nodular) and severity. The relative effectiveness of several topical and systemic agents has been established in clinical trials, making possible an algorithm of specific treatment decisions based on acne classification.

Mesh：

Substances：

Year:  2003        PMID： 12540312

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  6 in total

1.  Death inducing and cytoprotective autophagy in T-47D cells by two common antibacterial drugs: sulphathiazole and sulphacetamide.

Authors:  Raziye Mohammadpour; Shahrokh Safarian; Nader Sheibani; Saeed Norouzi; Atefeh Razazan
Journal:  Cell Biol Int       Date:  2013-03-01       Impact factor: 3.612

Review 2.  Carrier-based drug delivery system for treatment of acne.

Authors:  Amber Vyas; Avinesh Kumar Sonker; Bina Gidwani
Journal:  ScientificWorldJournal       Date:  2014-02-09

3.  Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients.

Authors:  Angela E Ryan-Kewley; David R Williams; Neill Hepburn; Ronald A Dixon
Journal:  Front Microbiol       Date:  2017-07-25       Impact factor: 5.640

4.  The Relationship between ABO Blood Groups and Acne Vulgaris.

Authors:  Erdinç Terzi; Belma Türsen; Pınar Dursun; Teoman Erdem; Ümit Türsen
Journal:  Saudi J Med Med Sci       Date:  2015-12-02

5.  Knowledge, Beliefs, and Psychosocial Effect of Acne Vulgaris among Saudi Acne Patients.

Authors:  Magdy A Darwish; Ahmed A Al-Rubaya
Journal:  ISRN Dermatol       Date:  2013-12-29

6.  Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study.

Authors:  Bela Jaswantlal Shah; Tharayil Kunneth Sumathy; Rachita Savalaram Dhurat; Raghunandan Govind Torsekar; Vishalakshi Viswanath; Jayesh Ishwardas Mukhi; Ganesh Kadhe; Pashmina Ahirrao
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.